2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease

M.A. Brodsky, J.M. Pollock, J. Grinstead, D. Lahna, D. Pettersson, W.D. Rooney (Portland, OR, USA)
Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic

V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, T. Lynch (Dublin, Ireland)
Unconventional chaperone inhibits alpha-synuclein amyloid formation by promoting off-pathway aggregation

J. Bieschke, E. Illes-Toth, M. Shah, N. Wu, S. Verzini, P. Selenko, E. Wanker (Saint Louis, MO, USA)
Understanding, predicting, and preventing falls in progressive supranuclear palsy

B.R. Bluett, I. Litvan, S. Cheng, J. Juncos, Y. Bordelon, D.E. Riley, D. Standaert, S.G. Reich, D.A. Hall, B. Kluger, D. Shprecher, C. Marras, J. Jankovic (Las Vegas, NV, USA)
Underutilization of physiotherapy for Parkinson’s disease in the United States

M.E. Fullard, D.P. Thibault, A. Hill, J. Fox, A.W. Willis (Philadelphia, PA, USA)
Unilateral dual lead thalamic deep brain stimulation improves refractory essential tremor

D. Isaacs, J.T. Butler, C. Tolleson, F. Phibbs, J. Fang, P. Hedera (Nashville, TN, USA)
Unilateral focused ultrasound thalamotomy in tremor-dominant Parkinson’s disease

B.B. Shah, D.S. Huss, S. Sperling, M.B. Harrison, J. Elias (Charlottesville, VA, USA)
Unilateral microelectrode mapping to guide bilateral deep brain stimulation electrode implantation: A retrospective study of anatomical lead placement and DBS programming outcomes

T.M. Herrington, K. Kanoff, J. Simon, E.N. Eskandar (Boston, MA, USA)
Unilateral MR-guided high intensity focused ultrasound ablation of the cerebellothalamic tract in essential tremor

S.R. Schreglmann, S. Hägele-Link, R. Bauer, N. Wegener, A. Lebeda, B. Werner, E. Martin, G. Kägi (London, United Kingdom)
Unilateral pallidotomy for cervical dystonia

S. Horisawa, T. Ishikawa, T. Hanada, T. Kawamata, T. Taira (Shinjuku, Japan)
Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease

H.A.G. Teive, D.C. Bertucci, R.P. Munhoz (Curitiba, Brazil)
Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia

S. Kurcova, K. Mensikova, L. Tuckova, J. Ehrmann, P. Kanovsky (Olomouc, Czech Republic)
Upper limb motor tests are related to clinical ratings of motor function in advanced Parkinson’s disease

M. Memedi, S. Aghanavesi, D. Nyholm, H. Askmark, S.M. Aquilonius, R. Constantinescu, F. Bergquist, A. Medvedev, A. Ericsson, F. Ohlsson, S. Lycke, J. Spira, M. Senek, J. Westin (Falun, Sweden)
Upregulated vascular endothelial nitric oxide synthase in Parkinson’s disease cases that have received subthalamic stimulation: A post-mortem evaluation

C. Mantanona, L. Hodgson, J.L. Elson, I.S. Pienaar (Newcastle upon Tyne, United Kingdom)
Urate and homocysteine: Changes in motor and cognitive symptoms in newly diagnosed Parkinson’s disease

I.J. Sleeman, R. Lawson, A. Yarnall, G. Duncan, F. Johnston, T. Khoo, D. Collerton, J.P. Taylor, D. Burn (Newcastle upon Tyne, United Kingdom)
Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)
Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease

J. DiFrancisco-Donoghue, A. Leder, M.K. Jung, W.G. Werner (Old Westbury, NY, USA)
Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

O.L. Tondiy (Kharkiv, Ukraine)
Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease

P.W. Ko, J.S. Park, K. Kang, H.W. Lee (Daegu, Korea)
Using wavelet coherence analysis to distinguish between tremor types

G. Kramer, M.A.J. Tijssen, N.M. Maurits, J.W. Elting (Groningen, Netherlands)
Utility of IgGs subtypes in hemolytic anemia prevention and treatment maintenance in patients treated with continous infusion of apomorphine

P. Sanchez-Lozano, E. Suarez, R. Ribacoba (Gijon, Spain)
Utility of the Mayo sleep questionnaire in predicting final autopsy diagnosis of alpha-synucleinopathy

D. Shprecher, J. Hentz, C. Adler, B. Dugger, H. Shill, E. Driver-Dunkley, S. Mehta, M. Sabbagh, C. Belden, R. Savica, L. Sue, T. Beach (Sun City, AZ, USA)
Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)
Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry

V. Felix Saunders, T. Simuni, K. Li, S. Luo (Chicago, IL, USA)
Utilization and longitudinal impact of anticholinergic use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry

V. Felix Saunders, K. Li, S. Luo, T. Simuni (Chicago, IL, USA)
Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease

J.L. Adams, R.A. Biemiller, K.L. Andrzejewski, S. Sharma, R.L. Rockhill, B.L. Greco, K.C. Hodgeman, P. Singh, S. Khanuja, T. Simuni, K.M. Biglan (Rochester, NY, USA)

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z